dr. mok on breakthrough therapies for alk-positive nsclc
Published 8 years ago • 636 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:02
dr. mok on overall survival data from the alex trial in alk lung cancer
-
2:12
dr. mok discusses updated data with pembrolizumab in nsclc
-
0:44
dr. mok on dacomitinib for first-line lung cancer treatment
-
1:28
dr. mok discusses developing lung cancer treatments
-
1:53
dr. mok on the utility of afatinib in lung cancer
-
0:49
dr. mok on plasma testing in lung cancer
-
6:53
upfront use of second-generation tkis in alk nsclc
-
3:31
the evolution of alk/ros1-targeted tkis
-
1:17
dr. xia on the frontline treatment landscape of alk-positive nsclc
-
8:55
choosing second-line therapy for alk nsclc
-
5:21
ceritinib alternative dosing for alk nsclc
-
1:05
dr. liu on sequencing therapy in alk-positive nsclc
-
1:07
dr. massarelli on first-line alk nsclc treatment
-
8:51
alk-positive nsclc
-
8:24
second-line treatment for alk-positive nsclc
-
0:59
dr. mok gives an overview of plasma testing approaches for lung cancer
-
8:24
second-line treatment for alk-positive nsclc
-
6:12
experience with ceritinib for alk nsclc
-
8:25
alk-positive lung cancer